Oral transmucosal fentanyl citrate for premedication in paediatric outpatients
Michael A. Ashburn(University of Pennsylvania), Theodore H. Stanley, James B. Streisand, Stephen Tarver(University of Utah), Nathan L. Pace, Annemiek Wilms Floet(Primary Children's Hospital), Roland W. Luijendijk(Primary Children's Hospital), Scott Mears(Primary Children's Hospital), Richard A. Elwyn(Primary Children's Hospital), Sandra M. Mulder(Primary Children's Hospital)
Cited by 68
Related Papers
Frequent Hypoxemia and Apnea after Sedation with Midazolam and Fentanyl
|Anesthesiology|1990|652
Adverse events associated with postoperative opioid analgesia: A systematic review
|Journal of Pain|2002|505
Management of chronic pain
|The Lancet|1999|368
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
|Kidney International|2011|258
Absorption and Bioavailability of Oral Transmucosal Fentanyl Citrate
|Anesthesiology|1991|248